Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104064
Filing Date
2025-08-06
Accepted
2025-08-06 16:15:51
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hlvx-20250630.htm   iXBRL 10-Q 2070046
2 EX-10.1 hlvx-ex10_1.htm EX-10.1 40826
3 EX-31.1 hlvx-ex31_1.htm EX-31.1 18434
4 EX-31.2 hlvx-ex31_2.htm EX-31.2 18377
5 EX-32.1 hlvx-ex32_1.htm EX-32.1 10390
6 EX-32.2 hlvx-ex32_2.htm EX-32.2 10220
  Complete submission text file 0000950170-25-104064.txt   9046484

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hlvx-20250630.xsd EX-101.SCH 1437005
75 EXTRACTED XBRL INSTANCE DOCUMENT hlvx-20250630_htm.xml XML 1566708
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41365 | Film No.: 251189789
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)